
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on th... CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.007506 | 1.87978963186 | 0.3993 | 0.4145 | 0.3331 | 440985 | 0.37758779 | CS |
4 | -0.013094 | -3.11836151465 | 0.4199 | 0.459 | 0.3331 | 546677 | 0.40160448 | CS |
12 | -0.234494 | -36.5654140028 | 0.6413 | 1.09 | 0.3331 | 1081203 | 0.5147142 | CS |
26 | -0.833194 | -67.1930645161 | 1.24 | 1.31 | 0.3331 | 659646 | 0.63867986 | CS |
52 | -2.063194 | -83.5301214575 | 2.47 | 2.4978 | 0.3331 | 748169 | 1.06724967 | CS |
156 | -5.173194 | -92.7095698925 | 5.58 | 6.14 | 0.3331 | 655046 | 2.26547302 | CS |
260 | -13.843194 | -97.1452210526 | 14.25 | 40.91 | 0.3331 | 772007 | 7.98294157 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 3.0374 (-10.53%) | 78.81M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5.795 (0.78%) | 50.21M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27.41 (0.04%) | 49.42M |
GNSGenius Group Limited | US$ 0.46 (43.75%) | 48.57M |
FXIiShares China Large Cap | US$ 34.2134 (2.62%) | 38.58M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約